Home
Who we are
What we offer
Media
More
Current studies:
MAPS' Phase III clinical trials using MDMA-assisted therapy for moderate to severe PTSD
Upcoming studies:
MDMA-assisted therapy as a treatment for Post Traumatic Stress in COVID-19 Frontline Healthcare Workers